Over the years, several molecules have been developed, able to selectively inhibit one of the different mutated IDH isoforms by reducing 2-HG levels and stimulating the differentiation of mutant IDH1/IDH2 acute myeloid leukemia (AML) cells [89,90,91,92]. Here, IDH2 is linked to acute myeloid leukemia.